Freestyle Libre 2 Sensor 1/Box

What is LIBRE2 Freestyle Libre 2 Sensor 1/Box?

The LIBRE2 Freestyle Libre 2 Sensor 1/Box is a single-pack glucose sensor from Abbott designed for continuous glucose monitoring. Worn on the back of the upper arm, it measures glucose levels in interstitial fluid for up to 14 days without requiring routine finger pricks. Compatible with the Freestyle Libre 2 reader or select smartphone apps, it delivers real-time glucose data through simple scans, helping users track trends and manage diabetes more effectively in daily life.

Key features

• 14-Day Wear — One sensor lasts up to two weeks for continuous monitoring.
• Fingerstick-Free Scanning — Get glucose readings by scanning the sensor with a reader or phone.
• Real-Time Alerts — Receive optional high and low glucose alarms directly to your device.
• Water-Resistant Design — Safe for swimming, showering, and active lifestyles.
• Discreet & Comfortable — Small, lightweight sensor blends under clothing and moves with the body.
• Smartphone Compatibility — Works with compatible mobile apps for on-the-go tracking.
• Simple Application — Includes applicator for quick, one-step sensor placement.

Who is LIBRE2 Freestyle Libre 2 Sensor 1/Box for?

This sensor is ideal for individuals with type 1 or type 2 diabetes who want a reliable, less invasive way to monitor glucose levels. It suits those managing insulin regimens, tracking dietary impacts, or seeking greater independence from fingerstick testing. Active users, parents monitoring children’s levels, and tech-savvy patients benefit from its seamless integration into daily routines.

How does LIBRE2 Freestyle Libre 2 Sensor 1/Box compare?

Compared to standard blood glucose meters, the Freestyle Libre 2 eliminates frequent fingersticks and provides trend data. It offers more convenience than traditional test strips and lancing devices. While similar to other CGMs, it stands out for its no-needle application, reader-based scanning, and proven accuracy without requiring calibration. It's more accessible than real-time implanted systems but lacks automatic insulin delivery integration found in some advanced hybrid systems.